21 CFR Part 11 is the FDA regulation that establishes requirements for electronic records and electronic signatures to be considered trustworthy and equivalent to paper records. The regulation applies to records created, modified, maintained, archived, retrieved, or transmitted under any FDA recordkeeping requirement. Compliance with Part 11 is essential for organizations using computerized systems in GxP activities.

What Is 21 CFR Part 11?

Part 11 defines the criteria under which the FDA considers electronic records to be reliable substitutes for paper records. It requires that electronic systems implement controls such as user authentication, audit trails, and authority checks. The regulation also specifies requirements for electronic signatures, including the use of distinct identification codes combined with passwords or biometric verification.

Principles

The core principle of Part 11 is that electronic records must be as trustworthy as paper records. This requires that systems prevent unauthorized access, detect unauthorized changes, and maintain secure audit trails. The regulation emphasizes that the person signing electronically must be uniquely identified and that signatures must be linked to their respective records.

Best Practices

Validate all computerized systems used to create or manage Part 11 records, and maintain documentation of validation activities. Implement role-based access controls, time-stamped audit trails, and secure electronic signature capabilities. Conduct periodic reviews to ensure systems remain compliant, and maintain procedures for managing passwords, account lockouts, and user termination.

Regulatory Requirements

21 CFR Part 11 requires system validation, audit trails, authority checks, device checks, and training for personnel using electronic systems. The FDA enforces Part 11 during inspections and can issue citations for inadequate electronic record controls. Organizations should also consider the interplay between Part 11 and EU Annex 11 when operating globally.

Conclusion

Compliance with 21 CFR Part 11 is mandatory for FDA-regulated organizations using electronic systems for GxP records. A well-designed Part 11 compliant system strengthens data integrity and provides significant operational advantages over paper-based processes. Organizations should approach Part 11 as an integral part of their overall data governance strategy.